BREAST CANCER PROF.NAZEM SHAMS. IS IT A SERIOUS PROBLEM ??

Slides:



Advertisements
Similar presentations
Clinical Pharmacology breast cancer
Advertisements

Mammary ductal carcinoma
Pimp Session: Breast By James Lee, MD.
TNM staging and prognosis Alexandru Eniu, MD, PhD Medical Oncologist Department of Breast Tumors Cancer Institute Ion Chiricuţă Cluj-Napoca, Romania.
History & Examination of the breast M K Alam.  Located between the subcutaneous fat and the fascia of the pectoralis major and serratus anterior muscles.
Connie Lee, M.D. UF Surgery
Medical Abbrevation Nantawarn Kitikannakorn, B.Pharm,Pharm.D.
Breast Pathology Helge Stalsberg MD University Hospital of North Norway.
National Program of Cancer Registries Education and Training Series How to Collect High Quality Cancer Surveillance Data.
Credit line: Breast. In: Greene, F.L., Compton, C.C., Fritz, A.G., et al., editors. AJCC Cancer Staging Atlas. New York: Springer, 2006: ©American.
What is TNM? TNM is a system for classifying malignant tumours ! It is a cancer staging system, which describes the extent of a person's cancer ! Most.
Histopathology and staging of breast cancer
Thorax Breasts.
Thorax Breasts.
What is cancer? A cancer is a malignant tumor, which are cells that multiply out of control, destroying healthy tissues (Dictionary)
A program of the UAMS College of Pharmacy
Breast Pathology Dr. M. Griffin.
1 Breast MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
M K ALAM Professor of Surgery ALMAAREFA COLLEGE
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Breast Cancer.
BREAST CANCER.
Morphology of breast cancer
Breast Cancer Hitham G. Falahi 4NU04. The most common cancer in females…
Breast Cancer Adapted From: SEER’s Training Web Site MCR Staff Supported by a Cooperative Agreement between.
Chapter 17.  Structure and Function  Subjective Data—Health History Questions  Objective Data—Physical Exam  Abnormal Findings Slide
Breast disease Dr. A. Basu MD.
Breast Clinical Correlation
Dilek Aygin Breast Cancer and Epidemiology Dilek Aygin.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
Prepared by: Hai Lam Lynn Yu Racheal Richie Trina Jones.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
Prof G . SIVAKUMAR, Emeritus Professor of Surgery &
CANCER BREAST OVERVIEW Dr. Ehab M.Oraby. INTRODUCTION  Breast is a modified sweat gland between skin and pectoral fascia.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
 General recommendations -adjuvant systemic therapy :with tamoxifen or multiple-chemotherapy agent :lower the incidence of recurrence by about 30% - in.
1 BREAST CANCER. Breast Cancer Breast cancer occurs when abnormal cells grow out of control in one or both breasts. They can invade nearby tissues and.
Directly Coded Summary Stage Breast Cancer National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention and Control,
Department of Surgery Ruijin Clinical Medical College Shanghai Jiao Tong University.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Breast Cancer Breast Cancer DR/FATMA AL-THOUBAITY ASSOCIATE PROFESSOR SURGICAL CONSULTANT.
Breast disease MUDr. Petr Šafář, CSc.. Anatomy of female breast.
Lisa Mifsud. Assessment and Management of Surgical Breast Disease.
Melanoma of the Skin Regional lymph nodes for skin sites of the head and neck. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd.
BREAST Begashaw M (MD). Introduction Modified sweat gland - produces milk Breast ca - most common cause of death Benign conditions  discomfort  confusion.
FACTS & FIGURES MOST FREQUENT SITES OF CANCER BREAST & UTERUS = WOMEN MALE & FEMALE BENIGN LESIONS MORE FREQUENT THAN MALIGNANT 182,000 NEW CASES.
The breast disease. Benign disease Present as; 1. Pain 2. Mass 3. Discharge 4. Abnormal appearance.
TNM Staging: Breast TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
Pathology.
Prof Mr Anil Sivasankaran
Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry
Breast Cancer Dr. Gehan Mohamed. Introduction Most common female cancer. The incidence of breast cancer increases with age. 80% of cases occur in post-menopausal.
Breast Anatomic sites and subsites of the breast. Compton, C.C., Byrd, D.R., et al., Editors. AJCC CancerStaging Atlas, 2nd Edition. New York: Springer,
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Breast Cancer Susan B. Kesmodel, MD, FACS
BREASTTUMORS Ch. 18 p (704 – 713). LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR.
History & Examination of the breast
What is Breast Cancer ? Abnormal cells develop from normal cells in the breast to form tumors Abnormal cells develop from normal cells in the breast to.
Gastric Cancer Pathology. Malignant Neoplasms of the Stomach Primary Adenocarcinoma (94%) Lymphoma (4%) Malignant GIST (1%) Haematogenous spread Breast.
CA BREAST: Clinical Aspects, Investigations, Staging
BREAST CANCER cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with.
BREAST CANCER Walid Galal El Shazly
الجامعة السورية الخاصة كلية الطب البشري قسم الجـراحـة
CLINICAL BREAST EXAMINATION
Dr. Sura Obay Al-Dewachi
Cancer Staging.
TNM 8 UPDATE Head and Neck SSG March 2018
Lung cancer staging and TNM classification
Dr. Damjanovich László Dr. Fülöp Balázs
Presentation transcript:

BREAST CANCER PROF.NAZEM SHAMS

IS IT A SERIOUS PROBLEM ??

TYPES OF BREAST CANCER In situ  Intraductal (DCIS)  Intralobular (LCIS) Invasive  Infiltrating ductal carcinoma  Tubular carcinoma  Medullary carcinoma  Mucinous carcinoma

PRESENTATION :

CANCER BREAST Skin manifestations: 1) Skin dimpling, Tethering & Puckering:- 2) Skin fixation, ulceration & fungation 3) Nipple retraction: 4) Paget's disease of nipple 5) Peau d’orange: 6) Cancerous satellite nodules (late sign) 7) Cancer en cuirasse (very late sign) 8) Mastitis carcinomatosa 9) Malignant edema of upper limb (brawny arm) 10) Dilated veins

CYSTSARCOMA PHYLLOIDE TUMORS

dimpling

Nipple retraction

Paget disease

Eczema

Peau d’orange

ulceration & fungation

Mastitis carcinomatosa

satellite nodules

Cancer en cuirasse

edema of upper limb

Winging of the scapula

RISK FACTORS OF BREAST CANCER

BREAST CANCER PATHOLOGY

Tx No evidence of primary tumor Tis Carcinoma in situ T1 Tumor 2cm or < T22 to 5 cm T3T> 5cm T4a extension to chest wall T4b edema (including peau d’orange), ulceration of skin, satellite nodules T4c T4a + T4b T4d Inflammatory carcinoma

N0no regional lymh node met. N1Movable ipsilateral axillary l.nod. N2Fixed ipsilateral axillary lymph n. or İnternal mammary lymh nodes N3-İpsilateral supraclavicular l.n. -Fixed ipsilateral axillary lymph n. and İnternal mammary lymh nodes -İpsilateral infraclavicular l.n.

M0 M1

STAGE 1 Tumor < 2.0 cm in greatest dimension No nodal involvement (N0) No metastases (M0)

STAGE II Tumor > 2.0 < 5 cm or Ipsilateral axillary lymph node (N1) No Metastasis (M0)

STAGE III Tumor > 5 cm (T3) or ipsilateral axillary lymph nodes fixed to each other or other structures (N2) involvement of ipsilateral internal mammary nodes (N3) Inflammatory carcinoma (T4d)

STAGE IV (METASTATIC BREAST CANCER) Any T Any N Metastasis (M1)

INVESTIGATIONS :